Mitsubishi UFJ Asset Management Co. Ltd. Boosts Position in Agilent Technologies, Inc. $A

Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 7.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 555,260 shares of the medical research company’s stock after acquiring an additional 40,225 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Agilent Technologies were worth $65,526,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in A. Aviva PLC increased its position in shares of Agilent Technologies by 6.6% during the second quarter. Aviva PLC now owns 212,969 shares of the medical research company’s stock valued at $25,132,000 after buying an additional 13,267 shares during the period. Prospera Financial Services Inc boosted its position in Agilent Technologies by 26.1% during the 2nd quarter. Prospera Financial Services Inc now owns 18,845 shares of the medical research company’s stock valued at $2,224,000 after acquiring an additional 3,906 shares in the last quarter. AGF Management Ltd. purchased a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $1,097,000. True Wealth Design LLC grew its holdings in shares of Agilent Technologies by 3,405.3% during the 2nd quarter. True Wealth Design LLC now owns 666 shares of the medical research company’s stock worth $79,000 after acquiring an additional 647 shares during the period. Finally, AE Wealth Management LLC raised its position in shares of Agilent Technologies by 4.8% in the 2nd quarter. AE Wealth Management LLC now owns 99,975 shares of the medical research company’s stock worth $11,798,000 after acquiring an additional 4,569 shares in the last quarter. 87.41% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A has been the topic of several recent research reports. Barclays upped their price target on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd. UBS Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and lifted their price target for the company from $130.00 to $170.00 in a research report on Wednesday, October 8th. Robert W. Baird boosted their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research note on Thursday, August 28th. Evercore ISI raised their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday, October 7th. Finally, TD Cowen boosted their price target on Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Stock Performance

Shares of A opened at $146.69 on Monday. The firm has a market capitalization of $41.59 billion, a P/E ratio of 34.43, a PEG ratio of 4.67 and a beta of 1.29. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The business has a fifty day moving average of $135.48 and a 200 day moving average of $122.56.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the firm posted $1.32 earnings per share. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is currently 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.